Cargando…

Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent

Detalles Bibliográficos
Autores principales: Vatsa, Rakhee, Sood, Ashwani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257099/
https://www.ncbi.nlm.nih.gov/pubmed/35345242
http://dx.doi.org/10.4103/ijmr.IJMR_2377_19
_version_ 1783718234424344576
author Vatsa, Rakhee
Sood, Ashwani
author_facet Vatsa, Rakhee
Sood, Ashwani
author_sort Vatsa, Rakhee
collection PubMed
description
format Online
Article
Text
id pubmed-8257099
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82570992021-07-14 Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent Vatsa, Rakhee Sood, Ashwani Indian J Med Res Innovations Wolters Kluwer - Medknow 2020-11 /pmc/articles/PMC8257099/ /pubmed/35345242 http://dx.doi.org/10.4103/ijmr.IJMR_2377_19 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Innovations
Vatsa, Rakhee
Sood, Ashwani
Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title_full Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title_fullStr Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title_full_unstemmed Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title_short Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent
title_sort theranostic role of radiolabelled rgd peptide in the treatment of radioiodine-resistant thyroid cancer: a novel agent
topic Innovations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257099/
https://www.ncbi.nlm.nih.gov/pubmed/35345242
http://dx.doi.org/10.4103/ijmr.IJMR_2377_19
work_keys_str_mv AT vatsarakhee theranosticroleofradiolabelledrgdpeptideinthetreatmentofradioiodineresistantthyroidcanceranovelagent
AT soodashwani theranosticroleofradiolabelledrgdpeptideinthetreatmentofradioiodineresistantthyroidcanceranovelagent